In which conditions does serum tryptase increase in a 71‑year‑old active woman with a level of 13.1 µg/L (normal ≤11) and seasonal hot flashes?

Elevated Tryptase: Causes and Clinical Significance

In a 71-year-old woman with a mildly elevated baseline tryptase of 13.1 µg/L, the most likely causes are hereditary alpha-tryptasemia (HαT), early/indolent systemic mastocytosis, or normal biological variation—with HαT being the most common explanation for persistent mild elevations in the general population. 1, 2

Understanding the Elevation

Your patient's tryptase level of 13.1 µg/L represents a mild elevation above the typical upper limit of 11 µg/L. This degree of elevation requires careful interpretation:

Primary Causes of Elevated Baseline Serum Tryptase

1. Hereditary Alpha-Tryptasemia (HαT) - Most Common

• HαT is the most frequent cause of persistently elevated baseline tryptase, affecting 4-6% of the general population 1, 2
• Results from germline duplications or triplications of the TPSAB1 gene encoding α-tryptase
• Tryptase levels typically range from 8-20 µg/L with duplications, higher with triplications 2
• Predominantly affects women (86.4% in recent studies) 3
• Can be completely asymptomatic or associated with multisystem symptoms including:
  • Cutaneous flushing and pruritus (relevant to your patient's hot flashes)
  • Dysautonomia
  • Functional gastrointestinal symptoms
  • Joint hypermobility
  • Increased risk of anaphylaxis 2, 3

2. Systemic Mastocytosis

• A raised resting tryptase concentration is usually due to α-tryptase secreted constitutively by increased numbers of mast cells 4
• Baseline tryptase >20 µg/L is a minor diagnostic criterion for systemic mastocytosis 5
• Your patient's level of 13.1 µg/L is below this threshold but doesn't exclude early disease
• Would require additional evaluation including skin examination for urticaria pigmentosa and potentially bone marrow biopsy if other criteria present 5

3. Other Myeloid Neoplasms

• Elevated tryptase can occur in myelodysplastic syndromes, myeloproliferative neoplasms, chronic myeloid leukemia, and acute myeloid leukemia 6
• Less likely given the modest elevation and absence of other hematologic abnormalities (presumably)

4. Renal Failure

• Acquired cause of elevated baseline tryptase 1
• Should be excluded with basic renal function testing

Acute vs. Baseline Tryptase: Critical Distinction

It is essential to understand that baseline tryptase (measured when asymptomatic) differs fundamentally from acute tryptase elevations:

Acute Tryptase Elevations (Anaphylaxis/Mast Cell Degranulation)

• During anaphylaxis, mature β-tryptase is released from mast cell granules, peaking at approximately 1 hour with a half-life of about 2 hours 4
• Optimal measurement window: 30 minutes to 2 hours after symptom onset 7
• A rise in serum tryptase indicates mast cell degranulation but does not discriminate between allergic and non-allergic anaphylaxis 4
• Important caveat: Anaphylaxis may be caused by basophil or complement activation, which are NOT associated with tryptase elevation—normal tryptase does not exclude anaphylaxis 4

Interpreting Tryptase Changes

The change in tryptase concentration is more helpful than the absolute concentration in diagnosing anaphylaxis 4. The "20 + 2 rule" states that acute tryptase should exceed baseline by at least 2 µg/L plus 1.2 times the baseline level 8.

Clinical Approach for Your Patient

Immediate Assessment

1. Determine if this is truly baseline tryptase:

   • Was the sample drawn when the patient was completely asymptomatic?
   • If drawn during or shortly after hot flashes, this could represent acute elevation
   • Repeat measurement at least 24 hours after any symptoms have resolved 7, 9

2. Evaluate for systemic mastocytosis:

   • Examine skin carefully for urticaria pigmentosa (brown macules/papules that urticate with stroking - Darier's sign)
   • Ask about episodic flushing, pruritus, abdominal cramping, diarrhea, bone pain
   • Complete blood count with differential
   • If suspicious, refer to hematology for bone marrow evaluation 5

3. Consider HαT genetic testing:

   • Given the mild elevation and female sex, HαT is highly probable 3
   • TPSAB1 copy number analysis can confirm diagnosis 2
   • This is particularly relevant as HαT is associated with increased anaphylaxis risk 3

4. Assess thyroid function:

   • Recent evidence shows association between HαT and thyroid disorders (27.3% prevalence) 3
   • Check TSH, free T4 given her hot flashes

Regarding the Hot Flashes

The seasonal hot flashes warrant specific consideration:

• Mast cell mediator release can cause flushing episodes that may be mistaken for menopausal hot flashes 10
• True mast cell-mediated flushing is typically accompanied by pruritus, tachycardia, or gastrointestinal symptoms
• Seasonal pattern (worse in summer) could suggest:
  • Heat-triggered mast cell degranulation
  • Increased allergen exposure
  • Normal menopausal symptoms unrelated to tryptase elevation

If hot flashes occur with other symptoms (pruritus, GI upset, hypotension), measure tryptase during an episode and compare to baseline 4, 8.

Risk Stratification and Management

Patients with elevated baseline tryptase, especially with insect venom allergy, have increased risk of severe anaphylactic reactions 8, 3. Your patient should:

• Carry epinephrine auto-injectors if any history of anaphylaxis or severe allergic reactions
• Be counseled about increased anaphylaxis risk
• Have tryptase levels documented before any surgical procedures or procedures requiring anesthesia 9
• Avoid mast cell degranulating drugs when possible (certain opioids, radiocontrast media without premedication)

Common Pitfalls to Avoid

1. Do not assume tryptase >11 µg/L automatically means mastocytosis - HαT is far more common 1, 2
2. Do not use the 20 µg/L cutoff rigidly - this is a minor criterion for mastocytosis but many patients with other conditions have persistently elevated levels between 15-20 µg/L 11
3. Do not measure tryptase during acute symptoms and interpret it as baseline 4, 7
4. Do not dismiss symptoms in patients with mildly elevated tryptase - even modest elevations from HαT can be associated with significant morbidity 2, 3

Bottom Line Recommendation

Order repeat baseline tryptase when completely asymptomatic, check CBC, renal function, and thyroid function. Consider TPSAB1 genetic testing for HαT given the mild elevation and female sex. Examine skin for mastocytosis. If hot flashes are accompanied by other symptoms suggesting mast cell activation, measure acute tryptase during an episode. The most likely diagnosis is HαT, which requires counseling about anaphylaxis risk but may not require specific treatment beyond symptom management and avoidance of triggers 2, 3.